ArQule Message Board - Msg: 1736088

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ArQule

ARQL 20.00

0.0%

Jan 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike Winn who wrote (69)	7/10/1997 11:54:00 AM
From: Doug Baer	of 399

from Briefing.com: ArQule Inc (ARQL) has entered into a collaboration with Wyeth-Ayerst Pharmaceuticals to discover drug candidates for a minimum of 15 of Wyeth-Ayerst's selected pharmaceutical targets. The American Home Products (AHP) unit will pay ArQule about $28 million, which includes a $2 million equity investment in ArQule to be paid in 1998...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next